Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Multidrug Cocktail in Soft Tissue Tumors
NCT05355597Phase 2Terminated
- Sponsor
- Atlantic Health System
- Start
- Jan 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Atlantic Health System. Primary endpoint: Pain Outcomes at 14 days. Started Jan 2021; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05355597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05355597.